7 October 2015 12:00-1:30pm ET
Sponsored By:
This webcast will focus on the legal liability and responsibility of a drug or device company incorporating consumer review—or any user-generated content (UGC)—functionality on a website or within social media channels. In particular, it will focus on the company's responsibility and liability when consumers post off-label use statements or describe adverse events in this context.
During this webcast, attendees will learn about the Communications Decency Act (CDA), a federal law that makes an Internet service provider immune from UGC on its service under many circumstances, as long as the provider is not controlling the statements to such a degree it makes them its own. FDA policy and statements regarding the CDA and social media will be explored as well as the interplay between the CDA and the Food, Drug, and Cosmetic Act.
Learning Levels: Basic and Intermediate
Learning Objectives Upon the webcast's conclusion, you will be able to:
Who Should Attend
Regulatory Affairs Professionals Society (RAPS)5635 Fishers Lane, Suite 400Rockville, Maryland 20852
raps@raps.org+1 301 770 2920
JoinMy RAPS DashboardLearn More
About UsTerms of UsePrivacy Policy